Drug delivery systems for differential release in combination therapy
Hongbin Zhang1, Guojie Wang, Huai Yang
1University of Science and Technology Beijing, School of Materials Science and Engineering, Beijing, PR China.
Expert Opinion on Drug Delivery
|January 14, 2011
Summary
Developing advanced drug delivery systems is crucial for effective combination cancer therapy. These systems enable the controlled, differential release of multiple therapeutic agents, enhancing treatment efficacy and clinical applicability.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Combination therapy is vital in cancer treatment, necessitating advanced drug delivery systems capable of releasing multiple agents differentially.
- Current limitations in cancer therapy drive the need for innovative drug delivery platforms that can manage multi-agent release profiles.
- Engineering established drug delivery systems and designing novel carriers are key to achieving desired therapeutic outcomes.
Purpose of the Study:
- To provide a comprehensive overview of multi-agent delivery systems developed over the past decade for combination therapy.
- To summarize and discuss various nanoscale to bulk-scale delivery systems, including liposomes, micelles, polymer conjugates, nano/microparticles, and hydrogels.
- To analyze the characteristics of these delivery systems, focusing on carrier structure, drug-loading methods, and release behaviors.
Main Methods:
- Literature review and synthesis of multi-agent delivery systems developed in the last 10 years.
- Categorization of delivery systems based on scale (nanoscale to bulk) and type (liposomes, micelles, etc.).
- Discussion of drug carrier structures, drug-loading techniques, release kinetics, and biological evaluation.
Main Results:
- Various multi-agent delivery systems have been engineered, offering diverse structural and functional characteristics.
- The chemical structure of drug delivery systems directly influences the controlled and differential release of therapeutic agents.
- Successful design of delivery systems allows for the differential release of multiple drugs, crucial for combination therapy.
Conclusions:
- The chemical architecture of drug delivery systems is paramount for controlling the release of multiple therapeutic agents in combination therapy.
- Differential drug release is achievable through meticulous design of appropriate delivery systems.
- Accelerating the clinical translation of these advanced delivery systems, alongside rigorous in vitro and in vivo evaluation, is essential for improving patient outcomes.
Related Concept Videos
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:22Modified-Release Drug Delivery Systems: Drug Release Characteristics
Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...